Latest News
Oct 31, 2021
EXCLUSIVE - 100% of Covid-19 Vaccine Deaths were caused by just 5% of the batches produced according to official Government data
An investigation of data found in the USA's Vaccine Adverse Event Reporting System (VAERS) has revealed that extremely high numbers of adverse reactions and dea
Oct 29, 2021
Horowitz: Lockdowns and vaccines have failed nursing home residents. Proactive treatment is the answer.
The entire purpose of the stunningly rushed shots was to protect the frail, elderly, and immunocompromised. Yet they are precisely the ones for whom the vaccine has failed – to the point that the CDC is now pushing a fourth shot of the same failed concoction even as the virus has already changed. Ni...
Oct 21, 2021
What Happened: Dr. Jay Bhattacharya on 19 Months of COVID
From the very beginning of the COVID-19 crisis, Dr. Jay Bhattacharya has been on the front lines of analyzing, studying, and even personally fighting the pandemic. In this wide-ranging interview, Dr. Bhattacharya takes us through how it started, how it spread throughout the world, the efficacy of lockdowns, the development and distribution of the vaccines, and the rise of the Delta variant. He delves into what we got right, what we got wrong, and what we got really wrong. Finally, Dr. Bhattacharya looks to the future and how we will learn to live with COVID rather than trying to extinguish it, and how we might be prepared to deal with another inevitable pandemic that we know will arrive at some point.
Sep 7, 2021
From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity
Background and Objectives Whether exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may predispose to the risk of cancer in individuals with no prior cancers is a crucial question that remains unclear. To confirm/refute possible relationships between exposure to the virus and ex novo insurgence of tumors, this study analyzed molecular mimicry and the related cross-reactive potential between SARS-CoV-2 spike glycoprotein (gp) antigen and human tumor-suppressor proteins. Materials and Methods Tumor-associated proteins were retrieved from UniProt database and analyzed for pentapeptide sharing with SARS-CoV-2 spike gp by using publicly available databases.
Results An impressively high level of molecular mimicry exists between SARS-CoV-2 spike gp and tumor-associated proteins. Numerically, 294 tumor-suppressor proteins share 308 pentapeptides with the viral antigen. Crucially, the shared peptides have a relevant immunologic potential by repeatedly occurring in experimentally validated epitopes. Such immunologic potential is of further relevancy in that most of the shared peptides are also present in infectious pathogens to which, in general, human population has already been exposed, thus indicating the possibility of immunologic imprint phenomena.
Conclusion This article described a vast peptide overlap between SARS-CoV-2 spike gp and tumor-suppressor proteins, and supports autoimmune cross-reactivity as a potential mechanism underlying prospective cancer insurgence following exposure to SARS-CoV-2. Clinically, the findings call for close surveillance of tumor sequelae that possibly could result from the current coronavirus pandemic.